Cipla launches rapid antigen test kits for detecting Covid-19
Pharmaceutical major Cipla Limited on Wednesday announced its partnership with the Premier Medical Corporation Private Limited for commercialisation of the rapid antigen test kits to detect Coronavirus disease (Covid-19) in India that will detect the viral disease in just about 15-20 minutes.
The company will start supplying the kits from this week, it said in a statement.
This is Cipla’s second launch in the diagnostics space after Elifast: SARS CoV-2 IgG ELISA Test Kit, which is a test kit to detect antibodies against the virus that causes Covid-19.
“In this collaboration, Cipla will be responsible for the marketing and distribution of the Rapid Antigen Detection Test for the qualitative detection of SARS-CoV-2 antigen that will be manufactured by Premier Medical Corporation Private Limited,” said the company in a statement issued on Wednesday.